Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Beyond medical therapies: clinicians' knowledge of cosmetic products in managing individuals with hair loss.

Bindra H, Sahota A, Jolliffe V.

Clin Exp Dermatol. 2019 Jun 24. doi: 10.1111/ced.14028. [Epub ahead of print] No abstract available.

PMID:
31233630
2.

Metabolic consequences of cystinuria.

Woodard LE, Welch RC, Veach RA, Beckermann TM, Sha F, Weinman EJ, Ikizler TA, Tischfield JA, Sahota A, Wilson MH.

BMC Nephrol. 2019 Jun 20;20(1):227. doi: 10.1186/s12882-019-1417-8.

3.

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C.

McGlynn EA, Adams JL, Kramer J, Sahota AK, Silverberg MJ, Shenkman E, Nelson DR.

JAMA Netw Open. 2019 Jun 5;2(6):e194765. doi: 10.1001/jamanetworkopen.2019.4765.

4.

A biomimetic magnetosome: formation of iron oxide within carboxylic acid terminated polymersomes.

Bain J, Legge CJ, Beattie DL, Sahota A, Dirks C, Lovett JR, Staniland SS.

Nanoscale. 2019 Jun 20;11(24):11617-11625. doi: 10.1039/c9nr00498j.

PMID:
31173027
5.

Managing monkey bites in returning travellers.

Kennedy M, Sahota A, Wiselka M, van Kampen JJA, Koopmans MPG, Tang JW.

J Infect. 2019 Jun;78(6):491-503. doi: 10.1016/j.jinf.2019.03.002. Epub 2019 Mar 5. No abstract available.

PMID:
30849439
6.

Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection.

Lawitz E, Poordad F, Anderson LJ, Vesay M, Kelly MM, Liu H, Gao W, Fernsler D, Asante-Appiah E, Robertson MN, Hanna GJ, Barr E, Butterton J, Kowdley KV, Hassanein T, Sahota A, Gordon SC, Yeh WW.

J Viral Hepat. 2019 Jun;26(6):675-684. doi: 10.1111/jvh.13079. Epub 2019 Mar 12.

PMID:
30739366
7.

Cystinuria: genetic aspects, mouse models, and a new approach to therapy.

Sahota A, Tischfield JA, Goldfarb DS, Ward MD, Hu L.

Urolithiasis. 2019 Feb;47(1):57-66. doi: 10.1007/s00240-018-1101-7. Epub 2018 Dec 4. Review.

PMID:
30515543
8.

Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.

Yanny B, Saab S, Durazo F, Latt N, Mitry A, Mikhail MM, Hanna RM, Aziz A, Sahota A.

Dig Dis Sci. 2018 Dec;63(12):3480-3486. doi: 10.1007/s10620-018-5283-1. Epub 2018 Sep 27.

PMID:
30259281
9.

PLAG1 expression and target genes in the hypothalamo-pituitary system in male mice.

Juma AR, Hall NE, Wong J, Gasperoni JG, Watanabe Y, Sahota A, Damdimopoulou PE, Grommen SVH, De Groef B.

Mol Cell Endocrinol. 2018 Dec 15;478:77-83. doi: 10.1016/j.mce.2018.07.009. Epub 2018 Jul 24.

PMID:
30048678
10.

Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 cases.

Scriven JE, Scobie A, Verlander NQ, Houston A, Collyns T, Cajic V, Kon OM, Mitchell T, Rahama O, Robinson A, Withama S, Wilson P, Maxwell D, Agranoff D, Davies E, Llewelyn M, Soo SS, Sahota A, Cooper MA, Hunter M, Tomlins J, Tiberi S, Kendall S, Dedicoat M, Alexander E, Fenech T, Zambon M, Lamagni T, Smith EG, Chand M.

Clin Microbiol Infect. 2018 Nov;24(11):1164-1170. doi: 10.1016/j.cmi.2018.04.027. Epub 2018 May 25.

11.

Design, synthesis, and evaluation of l-cystine diamides as l-cystine crystallization inhibitors for cystinuria.

Yang Y, Albanyan H, Lee S, Aloysius H, Liang JJ, Kholodovych V, Sahota A, Hu L.

Bioorg Med Chem Lett. 2018 May 1;28(8):1303-1308. doi: 10.1016/j.bmcl.2018.03.024. Epub 2018 Mar 10.

12.

Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.

Yanny BT, Latt NL, Saab S, Han S, Choi G, Kramer J, Sahota AK.

J Clin Gastroenterol. 2018 Nov/Dec;52(10):908-912. doi: 10.1097/MCG.0000000000000986.

PMID:
29334502
13.

Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment.

Lu M, Zhou Y, Haller IV, Romanelli RJ, VanWormer JJ, Rodriguez CV, Anderson H, Boscarino JA, Schmidt MA, Daida YG, Sahota A, Vincent J, Bowlus CL, Lindor K, Zhang T, Trudeau S, Li J, Rupp LB, Gordon SC; Fibrotic Liver Disease Consortium Investigators.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1342-1350.e1. doi: 10.1016/j.cgh.2017.12.033. Epub 2017 Dec 23.

PMID:
29277621
14.

Role of Molecular Recognition in l-Cystine Crystal Growth Inhibition.

Poloni LN, Zhu Z, Garcia-Vázquez N, Yu AC, Connors DM, Hu L, Sahota A, Ward MD, Shtukenberg AG.

Cryst Growth Des. 2017 May 3;17(5):2767-2781. doi: 10.1021/acs.cgd.7b00236. Epub 2017 Apr 13.

15.

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems.

Lu M, Li J, Haller IV, Romanelli RJ, VanWormer JJ, Rodriguez CV, Raebel MA, Boscarino JA, Schmidt MA, Daida YG, Sahota A, Vincent J, Bowlus CL, Lindor K, Rupp LB, Gordon SC; FOLD Investigators.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1333-1341.e6. doi: 10.1016/j.cgh.2017.10.018. Epub 2017 Oct 21.

PMID:
29066370
16.

An evaluation of general practitioners learning preferences in dermatology.

Soriano LF, Sahota A, Jolliffe V.

Educ Prim Care. 2018 Jan;29(1):54-55. doi: 10.1080/14739879.2017.1362667. Epub 2017 Aug 16. No abstract available.

PMID:
28812443
17.

Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety.

Latt NL, Yanny BT, Gharibian D, Gevorkyan R, Sahota AK.

World J Gastroenterol. 2017 Jul 14;23(26):4759-4766. doi: 10.3748/wjg.v23.i26.4759.

18.

Real-World Experiences With a Direct-Acting Antiviral Agent for Patients With Hepatitis C Virus Infection.

Louie V, Latt NL, Gharibian D, Sahota A, Yanny BT, Mittal R, Bider-Canfield Z, Cheetham TC.

Perm J. 2017;21:16-096. doi: 10.7812/TPP/16-096.

19.

Smartphones in the dermatology department: acceptable to patients?

Soriano LF, Jolliffe V, Sahota A.

Br J Dermatol. 2017 Dec;177(6):1754-1757. doi: 10.1111/bjd.15492. Epub 2017 Sep 26. No abstract available.

PMID:
28338227
20.

α-Lipoic acid treatment prevents cystine urolithiasis in a mouse model of cystinuria.

Zee T, Bose N, Zee J, Beck JN, Yang S, Parihar J, Yang M, Damodar S, Hall D, O'Leary MN, Ramanathan A, Gerona RR, Killilea DW, Chi T, Tischfield J, Sahota A, Kahn A, Stoller ML, Kapahi P.

Nat Med. 2017 Mar;23(3):288-290. doi: 10.1038/nm.4280. Epub 2017 Feb 6.

21.

Resource impact of managing suspected Middle East respiratory syndrome patients in a UK teaching hospital.

Veater J, Wong N, Stephenson I, Kirk-Granger H, Baxter LF, Cannon R, Wilson S, Atabani S, Sahota A, Bell D, Wiselka M, Tang JW.

J Hosp Infect. 2017 Mar;95(3):280-285. doi: 10.1016/j.jhin.2016.12.010. Epub 2016 Dec 18.

PMID:
28131646
22.

Measles - A tale of two sisters, vaccine failure, and the resurgence of an old foe.

Ahmed A, Sahota A, Stephenson I, Brown KE, Tang JW.

J Infect. 2017 Mar;74(3):318-320. doi: 10.1016/j.jinf.2016.12.012. Epub 2016 Dec 30. No abstract available.

PMID:
28043825
23.

Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection.

Kowdley KV, Sundaram V, Jeon CY, Qureshi K, Latt NL, Sahota A, Lott S, Curry MP, Tsai N, Chaiyakunapruk N, Lee Y, Petersen J, Buggisch P.

Hepatology. 2017 Apr;65(4):1094-1103. doi: 10.1002/hep.29005. Epub 2017 Feb 25. Review.

PMID:
28027579
24.

Cutaneous Mycobacterium abscessus infection following hair transplant.

Eustace K, Jolliffe V, Sahota A, Gholam K.

Clin Exp Dermatol. 2016 Oct;41(7):768-70. doi: 10.1111/ced.12900.

PMID:
27663154
25.

A simple breath test for tuberculosis using ion mobility: A pilot study.

Sahota AS, Gowda R, Arasaradnam RP, Daulton E, Savage RS, Skinner JR, Adams E, Ward SA, Covington JA.

Tuberculosis (Edinb). 2016 Jul;99:143-6. doi: 10.1016/j.tube.2016.05.005. Epub 2016 May 29.

26.

l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria.

Hu L, Yang Y, Aloysius H, Albanyan H, Yang M, Liang JJ, Yu A, Shtukenberg A, Poloni LN, Kholodovych V, Tischfield JA, Goldfarb DS, Ward MD, Sahota A.

J Med Chem. 2016 Aug 11;59(15):7293-8. doi: 10.1021/acs.jmedchem.6b00647. Epub 2016 Jul 26.

27.

Perceived benefits following completion of a clinical dermatology online programme for general practitioners.

Goiriz R, Butler C, Rajpopat S, Sahota A, Hubbard V, Jolliffe V.

Educ Prim Care. 2016 Jul;27(4):335-7. doi: 10.1080/14739879.2016.1197050. Epub 2016 Jul 4. No abstract available.

PMID:
27376864
28.

Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.

Werner RN, Stockfleth E, Connolly SM, Correia O, Erdmann R, Foley P, Gupta AK, Jacobs A, Kerl H, Lim HW, Martin G, Paquet M, Pariser DM, Rosumeck S, Röwert-Huber HJ, Sahota A, Sangueza OP, Shumack S, Sporbeck B, Swanson NA, Torezan L, Nast A; International League of Dermatological Societies; European Dermatology Forum.

J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2069-79. doi: 10.1111/jdv.13180. Epub 2015 Sep 14.

PMID:
26370093
29.

Adenine Phosphoribosyltransferase Deficiency.

Edvardsson VO, Palsson R, Sahota A.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2012 Aug 30 [updated 2015 Jun 18].

30.

Quiz page May 2015: crystalline nephropathy in an identical twin.

Agrawal V, Gibson PC, Sahota A, Nasr SH.

Am J Kidney Dis. 2015 May;65(5):A17-9. doi: 10.1053/j.ajkd.2014.12.019. No abstract available.

31.

Cystine growth inhibition through molecular mimicry: a new paradigm for the prevention of crystal diseases.

Lee MH, Sahota A, Ward MD, Goldfarb DS.

Curr Rheumatol Rep. 2015 May;17(5):33. doi: 10.1007/s11926-015-0510-7. Review.

32.

Novel cystine ester mimics for the treatment of cystinuria-induced urolithiasis in a knockout mouse model.

Sahota A, Parihar JS, Capaccione KM, Yang M, Noll K, Gordon D, Reimer D, Yang I, Buckley BT, Polunas M, Reuhl KR, Lewis MR, Ward MD, Goldfarb DS, Tischfield JA.

Urology. 2014 Nov;84(5):1249.e9-15. doi: 10.1016/j.urology.2014.07.043. Epub 2014 Oct 24.

33.

Fever, nodulobullous eruption and swollen ears.

Golberg O, Burd R, Sahota A, Wiselka M.

Clin Exp Dermatol. 2013 Oct;38(7):811-3. doi: 10.1111/ced.12093. Epub 2013 Apr 3. No abstract available.

PMID:
23551278
34.

Certification in molecular pathology in the United States: an update from the Association for Molecular Pathology Training and Education Committee.

Mackinnon AC Jr, Wang YL, Sahota A, Yeung CC, Weck KE.

J Mol Diagn. 2012 Nov;14(6):541-9. doi: 10.1016/j.jmoldx.2012.05.004. Epub 2012 Aug 24.

35.

Contractile and electrophysiologic characterization of optimized self-organizing engineered heart tissue.

Sondergaard CS, Mathews G, Wang L, Jeffreys A, Sahota A, Wood M, Ripplinger CM, Si MS.

Ann Thorac Surg. 2012 Oct;94(4):1241-8; discussion 1249. doi: 10.1016/j.athoracsur.2012.04.098. Epub 2012 Jul 12.

36.

Computational analysis of contractility in engineered heart tissue.

Mathews G, Sondergaard C, Jeffreys A, Childs W, Le BL, Sahota A, Najibi S, Nolta J, Si MS.

IEEE Trans Biomed Eng. 2012 May;59(5):1429-35. doi: 10.1109/TBME.2012.2187899. Epub 2012 Feb 22.

PMID:
22361653
37.

MRI in evaluation of perianal fistula.

George U, Sahota A, Rathore S.

J Med Imaging Radiat Oncol. 2011 Aug;55(4):391-400. doi: 10.1111/j.1754-9485.2011.02268.x. Review.

PMID:
21843174
38.

Seasonal cutaneous sarcoidosis: a photo-induced variant.

Wong S, Pearce C, Markiewicz D, Sahota A.

Photodermatol Photoimmunol Photomed. 2011 Jun;27(3):156-8. doi: 10.1111/j.1600-0781.2011.00579.x.

PMID:
21535170
39.

Does capsule endoscopy improve outcomes in obscure gastrointestinal bleeding? Randomized trial versus dedicated small bowel radiography.

Laine L, Sahota A, Shah A.

Gastroenterology. 2010 May;138(5):1673-1680.e1; quiz e11-2. doi: 10.1053/j.gastro.2010.01.047. Epub 2010 Feb 2.

PMID:
20138043
40.

2,8-dihydroxyadenine nephrolithiasis induces developmental stage-specific alterations in gene expression in mouse kidney.

Chen J, Chen Y, Capizzi S, Yang M, Deng L, Bledsoe SB, Evan AP, Tischfield JA, Sahota A.

Urology. 2010 Apr;75(4):914-22. doi: 10.1016/j.urology.2009.10.031. Epub 2009 Dec 29.

41.

A novel SULF1 splice variant inhibits Wnt signalling but enhances angiogenesis by opposing SULF1 activity.

Sahota AP, Dhoot GK.

Exp Cell Res. 2009 Oct 1;315(16):2752-64. doi: 10.1016/j.yexcr.2009.06.029. Epub 2009 Jul 3.

PMID:
19577565
42.

Bladder outlet obstruction in male cystinuria mice.

Ercolani M, Sahota A, Schuler C, Yang M, Evan AP, Reimer D, Barone JG, Tischfield JA, Levin RM.

Int Urol Nephrol. 2010 Mar;42(1):57-63. doi: 10.1007/s11255-009-9597-y. Epub 2009 May 31.

43.

An unusual cause of elevated values on liver function tests in a liver transplant patient.

Jain A, Sahota A, Alshak NS, Tung JK.

Perm J. 2009 Spring;13(2):58-60. No abstract available.

44.

Foreign-body ingestion: characteristics and outcomes in a lower socioeconomic population with predominantly intentional ingestion.

Palta R, Sahota A, Bemarki A, Salama P, Simpson N, Laine L.

Gastrointest Endosc. 2009 Mar;69(3 Pt 1):426-33. doi: 10.1016/j.gie.2008.05.072. Epub 2008 Nov 18.

PMID:
19019363
45.

Vulval intraepithelial neoplasia and periungual Bowen's disease concordant for mucosal (HPV-34) and epidermodysplasia verruciformis (HPV-21) human papillomavirus types.

Ekeowa-Anderson AL, Harwood CA, Perrett CM, Sahota A, Annan H, Ran H, Leigh IM, Gibbon KL.

Clin Exp Dermatol. 2007 May;32(3):304-7. Epub 2007 Mar 14.

46.

Preparing DNA from Mammalian sources for genotyping.

Sahota A, Brooks AI, Tischfield JA.

CSH Protoc. 2007 Aug 1;2007:pdb.top19. doi: 10.1101/pdb.top19.

PMID:
21357154
47.

Preparing DNA from saliva for genotyping.

Sahota A, Brooks AI, Tischfield JA.

CSH Protoc. 2007 Aug 1;2007:pdb.prot4831. doi: 10.1101/pdb.prot4831.

PMID:
21357152
48.

Preparing DNA from blood for genotyping.

Sahota A, Brooks AI, Tischfield JA, King IB.

CSH Protoc. 2007 Aug 1;2007:pdb.prot4830. doi: 10.1101/pdb.prot4830.

PMID:
21357151
49.

Preparing DNA from cell pellets for genotyping.

Sahota A, Brooks AI, Tischfield JA.

CSH Protoc. 2007 Aug 1;2007:pdb.prot4829. doi: 10.1101/pdb.prot4829.

PMID:
21357150
50.

Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue.

Hakim AJ, Sahota A.

Clin Dermatol. 2006 Nov-Dec;24(6):521-33. Review.

PMID:
17113970

Supplemental Content

Loading ...
Support Center